Meta(bolism) + Fines

Frontier of Multimodal Cure and Care

"MetaFines Co., Ltd., established in 2018, is a clinical-stage biotech company focused on developing innovative therapies that target cellular metabolism"

We are advancing both single and combination therapies by targeting core metabolic pathways.
Our patented low-toxicity treatments work by demonstrating synergistic effects of different cytostatic agents in a single molecule with a unique mechanism of action.

In addition to cancer, we are developing therapies to combat complications including cachexia, muscle dystrophy, sarcopenia,
and degenerative diseases like obesity by rebalancing cellular metabolism.